Agios Pharmaceuticals | DETTE



Debt Changement Date
AbbVie USD 67.14B 3.94B 2024-12
Agios Pharmaceuticals USD 0 0 2024-12
Alnylam Pharmaceuticals USD 1.02B 967K 2024-12
Amgen USD 60.1B 299M 2024-12
Arrowhead Research USD 409.41M 16.23M 2024-12
Astellas Pharma JPY 915.36B 12.13B 2024-12
AstraZeneca USD 30.3B 1.27B 2024-12
Bayer EUR 40.7B 465M 2024-12
Biogen USD 6.3B 1.9M 2024-12
BioMarin Pharmaceutical USD 596.24M 1.61M 2024-12
Bristol-Myers Squibb USD 49.65B 103M 2024-12
Daiichi Sankyo JPY 101.43B 94M 2024-12
Eli Lilly USD 33.64B 2.52B 2024-12
Exelixis USD 0 0 2025-01
Gilead Sciences USD 26.71B 3.46B 2024-12
GlaxoSmithKline GBP 16.99B 927M 2024-12
Incyte USD 37.96M 5.81M 2024-12
Ionis Pharmaceuticals USD 1.25B 32.8M 2024-12
Merck USD 37.11B 1.02B 2024-12
Moderna USD 62M 593M 2024-12
Novartis USD 31.26B 828M 2024-12
Novartis USD 31.26B 828M 2024-12
Pfizer USD 64.35B 3.35B 2024-12
Regeneron Pharmaceuticals USD 2.7B 400K 2024-12
Roche Holding CHF 34.44B 5.23B 2024-06
Sarepta Therapeutics USD 1.14B 90.44M 2024-12
Vertex Pharmaceuticals USD 112.8M 1.2M 2024-12



Agios Pharmaceuticals DETTE - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2025.